Educational content on VJHemOnc is intended for healthcare professionals only. By visiting this website and accessing this information you confirm that you are a healthcare professional.

Share this video  

IMS 2023 | Clonal hematopoiesis in multiple myeloma and implications for therapy

Adam Sperling, MD, PhD, Dana-Farber Cancer Institute, Boston, MA, shares some insights into the role of clonal hematopoiesis (CH) in multiple myeloma and how this may impact treatment approaches for patients. This interview took place at the 20th International Myeloma Society (IMS) Annual Meeting, held in Athens, Greece.

These works are owned by Magdalen Medical Publishing (MMP) and are protected by copyright laws and treaties around the world. All rights are reserved.


Consulting: Novartis, Roche